Delphi advisor to Olink Holding AB (publ) on the USD 406 million initial public offering and listing on Nasdaq Global Market

Advokatfirman Delphi has advised Olink Holding AB (publ) in the USD 406 million initial public offering of American Depositary Shares (ADSs) and listing on Nasdaq Global Market. Each ADS represents one share in the company and the ADSs in the offering consisted of both newly issued shares and existing shares sold by certain shareholders of the company, including, among others, Summa Equity as the majority shareholder of Olink. The offer gives the company a value of approximately USD 2.38 billion.

Olink (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science.

Delphi’s team primarily consisted of Annika Melin Jakobsson, Andreas Wirén, Mats Dahlberg, Pekka Frölander and Matilda Karlsson. In addition, a large number of lawyers at Delphi were involved in the work in connection with the initial public offering and listing.